Profil

Lenaerts Charline

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service d'Analyse pharmaceutique

Main Referenced Co-authors
BLANKERT, Bertrand  (35)
Bond, Liz (15)
Tuytten, Robin (15)
WELLS, Mathilde  (5)
Delporte, Cédric (4)
Main Referenced Keywords
Preeclampsia (14); Marinobufagenin (13); Bufo marinus (8); biomarker (6); LC-MS/MS (6);
Main Referenced Unit & Research Centers
CISMA - Centre Interdisciplinaire de Spectrométrie de Masse (19)
UMHAP - Centre de Recherche UMONS-Ambroise Paré (15)
CREMH - Mind & Health (1)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (36)
Chemistry (32)
General & internal medicine (15)
Reproductive medicine (gynecology, andrology, obstetrics) (11)
Endocrinology, metabolism & nutrition (9)

Publications (total 38)

The most downloaded
17 downloads
Lenaerts, C., Wells, M., Hambye, S., & Blankert, B. (17 January 2019). Marinobufagenin extraction from Rhinella marina toad glands: alternative approaches for a systematized strategy. Journal of Separation Science, 42 (7), 1384 - 1392. doi:10.1002/jssc.201800879 https://hdl.handle.net/20.500.12907/36627

The most cited

12 citations (Scopus®)

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (17 May 2018). Revealing of endogenous Marinobufagin by an ultra-specific and sensitive UHPLC-MS/MS assay in pregnant women. Talanta, 187, 193-199. https://hdl.handle.net/20.500.12907/22762

Lenaerts, C. (2019). Défis et stratégies novatrices pour la quantification de la marinobufagénine : application au syndrome de prééclampsie [Doctoral thesis, Université de Mons]. ORBi UMONS-University of Mons. https://orbi.umons.ac.be/handle/20.500.12907/11041

Lenaerts, C., Wells, M., Hambye, S., & Blankert, B. (17 January 2019). Marinobufagenin extraction from Rhinella marina toad glands: alternative approaches for a systematized strategy. Journal of Separation Science, 42 (7), 1384 - 1392. doi:10.1002/jssc.201800879
Peer Reviewed verified by ORBi

Lenaerts, C., Wells, M., Hambye, S., & Blankert, B. (12 September 2018). Quantification of endogenous marinobufagin by a high-specific and very sensitive UPLC-MS/MS assay in non-patological pregnancy and preeclampsia [Paper presentation]. DA-PBA 2018 : 11th International symposium on Drug Analysis - 29th International Symposium on Pharmaceutical and Biomedical Analysis, Leuven, Belgium.
Peer reviewed

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (17 May 2018). Revealing of endogenous Marinobufagin by an ultra-specific and sensitive UHPLC-MS/MS assay in pregnant women. Talanta, 187, 193-199.
Peer Reviewed verified by ORBi

Laenens, E., Lenaerts, C., & Blankert, B. (2017). Le venin de crapaud buffle au secours des femmes enceintes. LUMONS - élément.

Wells, M., Lenaerts, C., & Blankert, B. (2017). Amélioration des techniques d'extraction de la marinobufagénine de matrices complexes [Master’s dissertation, Université de Mons]. ORBi UMONS-University of Mons. https://orbi.umons.ac.be/handle/20.500.12907/9996

Lenaerts, C., & Blankert, B. (2017). Le venin thérapeutique - Quand le poison devient un remède.

Wells, M., Lenaerts, C., Hambye, S., & Blankert, B. (28 March 2017). Stratégies d'extraction et de purification de la Marinobufagénine à partir du venin du crapaud Bufo marinus [Poster presentation]. 12ème Congrès de l'Association Francophone des Sciences Séparatives, Paris, France.

Lenaerts, C., & Blankert, B. (2017). le venin de crapaud pour diagnostiquer un syndrome préoccupant chez la femme enceinte.

Blankert, B., & Lenaerts, C. (2017). UMons: vers un diagnostic au venin de crapaud. Groupe Sud Presse.

Lenaerts, C., & Blankert, B. (2017). Intérêt des venins dans le diagnostic thérapeutique.

Lenaerts, C., Blankert, B., Bond, L., Tuytten, R., Van Antwerpen, P., & Delporte, C. (17 October 2016). Elaboration of a quantification assay of marinobufagenin in human plasma: a novel approach based on response factor quantification by LC-MS/MS [Paper presentation]. 19th Forum of Pharmaceutical Sciences, Bruxelles, Belgium.

Wells, M., Lenaerts, C., Hambye, S., & Blankert, B. (17 October 2016). Extraction and purification strategies of marinobufagenin from bufo marinus toad venom [Paper presentation]. 19th Forum of Pharmaceutical Sciences, Bruxelles, Belgium.

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (15 August 2016). Early prediction of preeclampsia risk assessment: analytical determination for marinobufagenin in pregnant women. Journal of Maternal-Fetal and Neonatal Medicine, 29, 18.
Peer Reviewed verified by ORBi

Lenaerts, C., Tuytten, R., Bond, L., Delporte, C., Van Antwerpen, P., & Blankert, B. (06 July 2016). A LC-MS assay for identification and quantification of marinobufagenin in human: a novel approach for preeclampsia risk evaluation [Paper presentation]. MASCL, Salzburg, Austria.
Peer reviewed

Wells, M., Lenaerts, C., & Blankert, B. (2016). Exploration et perfectionnement des techniques de purification de la Marinobufagénine à partir du venin de Bufo Marinus.

Lenaerts, C., Tuytten, R., Bond, L., Delporte, C., Van Antwerpen, P., & Blankert, B. (12 May 2016). Early prediction of preeclampsia risk assessment: analytical determination for marinobufagenin in pregnant women [Paper presentation]. Second International Congress on Maternal Hemodynamics, Rome, Italy.
Peer reviewed

Lenaerts, C., Tuytten, R., Bond, L., Delporte, C., Van Antwerpen, P., & Blankert, B. (27 January 2016). Setting up of a LC-MS/MS assay for identification and quantification of MBG in pregnant women for preeclampsia risk evaluation [Poster presentation]. HTC-14 ; 14th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology, Ghent, Belgium.

Lenaerts, C., & Blankert, B. (15 October 2015). Marinobufagenin as a promising preeclampsia assessment marker [Paper presentation]. Séminaire Hôpital Ambroise Paré, Mons, Belgium.

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (24 September 2015). Marinobufagenin as a promising preeclampsia risk assessment marker: purification from toad venom and LC-MS identification in human plasma [Paper presentation]. ISSHP (International Society for the Study of Hypertension in Pregnancy) 2015, Budapest, Hungary.
Peer reviewed

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (13 July 2015). Marinobufagenin as a potential biomarker for preeclampsia risk assessment: purification from Bufo Marinus toad venom as support for a human plasma LC-MS/MS assay [Paper presentation]. Joint meeting of the GP-TCM Research Association, the TCM Chemistry Specialty Committee and the TCM Pharmaceutical Analysis Specialty Committee of the World Federation of Chinese Medicine Societies, Mons, Belgium.
Peer reviewed

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (09 July 2015). Marinobufagenin as a promising preeclampsia risk assessment marker: purification from toad venom and LC-MS identification in human plasma. Pregnancy Hypertension, 5 (3), 213-214.
Peer reviewed

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (15 May 2015). LC-MS/MS analysis of marinobufagenin in human plasma : an encouraging predictive tool for preeclampsia risk stratification [Paper presentation]. Forum SBSP 2015, Blankenberge, Belgium.

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (15 May 2015). Marinobufagenin : extraction and LC-MS/MS identification in toad venom and human plasma as a promising preeclampsia risk stratification tool [Poster presentation]. Bioforum 2015- ULG, Liège, Belgium.

Bond, L., Nolan, C., Hyland, K., Lenaerts, C., Baker, P., Kenny, L., & Tuytten, R. (26 October 2014). PREECLAMPSIA RISK STRATIFICATION EARLY IN PREGNANCY: LEVERAGING A PROMISING METABOLOMICS DISCOVERY INTO A LC-MS BASED CLINICAL ASSAY [Poster presentation]. ISSHP (International Society of the Study of Hypertension in Pregnancy) World Congress, New Orleans, United States - Louisiana.

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (17 October 2014). Analysis of marinobufagenin in plasma for preeclampsia risk assessment: a promising early predictive tool [Paper presentation]. 1st International Congress on Maternal Hemodynamics, Hasselt, Belgium.
Peer reviewed

Bond, L., Lenaerts, C., Benton, C., Baker, P., Kenny, L., & Tuytten, R. (04 September 2014). Preeclampsia risk stratification early in pregnancy: Conversion of a promising metabolomics discovery into a LC-MS based clinical assay [Poster presentation]. MSACL, Salzburg, Austria.

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (03 September 2014). Identification of marinobufagenin in plasma as a promising LC-MS assay for preeclampsia risk assessment [Poster presentation]. MSACL, Salzburg, Austria.

Lenaerts, C., Deplechin, T., & Blankert, B. (22 June 2014). Set up of a solid phase extraction (SPE) method of marinobufagenin from human plasma [Poster presentation]. Drug Analysis, Liège, Belgium.

Lenaerts, C., Deplechin, T., & Blankert, B. (13 February 2014). Purification and extraction of marinobufagenin from Bufo Marinus toad venom and from human plasma [Poster presentation]. 6ème Journée Scientifique du Pôle hainuyer, Mons, Belgium.

Lenaerts, C., Demeyer, M., Gerbaux, P., & Blankert, B. (17 October 2013). Challenges and novel strategies for quantification of marinobufagenin within the framework of preeclampsia [Paper presentation]. 17th Forum of Pharmaceutical Sciences, Spa, Belgium.

Lenaerts, C., Larcy, C., & Blankert, B. (13 June 2013). Analytical aspects of marinobufagenin and its applications in the diagnosis of preeclampsia [Poster presentation]. ISSHP (International Society of the Study of Hypertension in Pregnancy) European Congress, Tromso, Norway.

Lenaerts, C., Larcy, C., & Blankert, B. (01 June 2013). Analytical aspects of marinobufagenin and its applications in the diagnosis of preeclampsia. Pregnancy Hypertension, 3, 99.
Peer reviewed

Lenaerts, C., & Blankert, B. (24 May 2013). Marinobufagenin : a new diagnosis target for preeclampsia syndrome? [Poster presentation]. 1st Health Institute Day, Mons, Belgium.

Lenaerts, C., & Blankert, B. (12 March 2013). Marinobufagenin: a new diagnostic target for preeclampsia syndrome? [Poster presentation]. 7ème édition de la Matinée de Chercheurs, Mons, Belgium.

Lenaerts, C., Helvenstein, M., & Blankert, B. (29 January 2013). Marinobufagenin and its applications in the diagnosis of preeclampsia [Poster presentation]. Journée scientifique des doctorants en Sciences Biomédicales et Pharmaceutiques: 'New tools and strategies in identification of pathology-related biomarkers', UMONS, Belgium.

Lenaerts, C., Demeyer, M., Gerbaux, P., & Blankert, B. (01 January 2013). Analytical aspects of marinobufagenin. Clinica Chimica Acta, 421, 193-201.
Peer Reviewed verified by ORBi

Lenaerts, C., & Blankert, B. (16 October 2012). Analytical aspects of marinobufagenin and its applications in the diagnostic of preeclampsia [Paper presentation]. VIIe PhD Day de l'école doctorale en sciences pharmaceutiques ULB/UMONS, Bruxelles, Belgium.

Contact ORBi UMONS